Dr. Karan Sood
@QuantumOnc
Stoic | Molecular Oncology | Medical Oncology | Manchester United | Metallica | CR7 | Schumacher | Federer | Bryant | Views are my own
Time to remind everyone. Every committee is put in place in order to make processes more “efficient” but inevitably cause delays and prolongs timelines.
Thrilled to officially join the 2025–2026 @ASCO Trainee & Early Career Advisory Group (@ASCOTECAG )! 💼🌟 This powerhouse team brings together trainees from across the country united by a shared mission: championing the next generation of oncologists. Grateful for the…
@dr_yakupergun @oncoblogger I'd like to add that for oncologists in low- and middle-income countries (LMICs), social media is not a threat—it’s a lifeline. Before platforms like X (formerly Twitter), global oncology discourse was largely one-sided: knowledge flowed from elite…
@oncoblogger et al.'s excellent viewpoint on social media's role in addressing biases in oncology is a must-read💯 (Also, my brief comment on the topic: On balancing the risks and opportunities of social media👇) jamanetwork.com/journals/jamao…
🎖️Day 2 of #ASCO25 at @ASCOTECAG lounge with a full agenda! @ASCO ✨Come join us for excellent panels, networking opportunities, one-on-one mentorship and to relax, recharge and grab snacks & coffee! Agenda 👉cdn.bfldr.com/KOIHB2Q3/as/7c… #MedEd @RManochakian @NazliDizman
🚨 Just published in JCO Global Oncology 📢 Our phase III METRO-CHASE trial shows triple oral metronomic chemotherapy significantly improves survival in platinum-refractory. #HeadAndNeckCancer. 🔗 doi.org/10.1200/GO-25-… #oncology #cancerresearch
💰 The 2026 NCI budget drops from $7.22B to $4.10B—a 43% cut 📉. How will this impact the future of cancer research? 🧠 Has your research been impacted? ARTICLE: oncologytube.com/2026-cancer-re… YOUTUBE: youtu.be/DQrD_PpVMF4 @OncoAlert @ASCO @marklewismd @StephenVLiu @mtmdphd…
Proud to share our new publication in @NatureComms , led by @ogarrieta and an extraordinary team effort @incanMX . Alectinib + bevacizumab as 1L therapy in metastatic ALK+ NSCLC 🫁: 🔹 ORR: 100% 🔹 12 & 36 month PFS: 97% & 64.2% 🔹 36-month intracranial PFS: 87.8% 👉While not…
Second Primary malignancies (SPM) post transplant are rarely reported from India. It requires really long follow-up of big cohorts to show this data. Happy to share our recent publication on SPM post transplant in myeloma link.springer.com/article/10.100…
Ph2 trial in🇨🇳 (n=100) in unresectable stage III NSCLC: anti–PD-1 induction therapy achieved 61.7% MPR. ⚠️BST1 (AUC 0.78) identified as a predictive biomarker in PD-L1–neg/unevaluable tumors, linked to CD8+/NK infiltration and better EFS/OS (p<0.05) rdcu.be/emeHn
Excellent response to tramatinib plus low-dose doxorubicin in RAF1-mutated sarcoma. ecancer.org/en/journal/art… 1. CD 34 and S 100 coexpression (just like NTRK and RET fusion sarcomas) 2. PZRN3-RAF1 misdiagnosed as DFSP
Does the dose of Dexamethasone matter in the management of MM? Tune into the @IndMyAcGp Journal club on 22 May at 1730h IST for a better understanding of the long-considered backbone of MM therapy. Also, hear about the MM care in Sri Lanka. @RahulBanerjeeMD @buddhikaprabat3
This is so reassuring @KalinskyKevin #TNBC
TILs & Outcomes in TNBC from #ESMOBreast25 Presented by Dr. Kevin Kalinsky Even after pCR, low sTILs (<30%) = worse prognosis in node+ TNBC DRFS: 94.7% vs 82.6% OS: 97.0% vs 84.3% Drop of ~13% despite pCR Immune microenvironment matters! THAT MEANS Not all PCR are Same 👈…
One of my favorite posters of #ESMOBreast25, addressing an important question: 👉What is the outcome of post-T-DXd treatments in HER2+ mBC? Does T-DXd-induced HER2 downregulation impair the activity of subsequent T-DM1? TKIs? Chemo? Answer below 1/4
Another DNB thesis lands in my inbox—joining its MD cousins. My task is to evaluate it. A formality, really. The postgraduate has written it, the professor has supervised it—or so the paperwork claims. I enter the username, type the password, and open the file—without hope. An…
1/n..Under the aegis of @CRSF_IN and guidance of @DrVijayPatil11, @VanitaNoronha, Dr. Kumar sir, our long-awaited study on Triple Metronomic therapy was published in @TheCancerLetter. Please read and comment. kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…
Lessons from Dr Emil Freireich False negative results are much more harmful than false positives. With false negatives, whole fields of inquiry may be shuttered. With false positives, others will try to replicate the data or build on it, and the false positive will be exposed.
If you’re looking for a great review on approach to diagnosing and treating patients with Pheo and Para- look no further. @AlkaissiHussam @JaydiDelRivero #KarelPacak et al discuss the latest in the care of patients with Pheo/Para in this excellent review 🔥 @PheoPara @NCFCancer…
🎉 Out work from @pmcancercentre is out now in the European Journal of Hematology! Outcomes of allogeneic transplantation for MDS/MPN overlap neoplasms in the contemporary era 🙌🏽 @Hans_BMTProgram @SergioRdzRdz onlinelibrary.wiley.com/doi/abs/10.111…
NEWS FROM INDUSTRY🚨 Source AstraZeneca DESTINY-Breast11 Update The DESTINY-Breast11 Phase III trial sees trastuzumab deruxtecan followed by paclitaxel, trastuzumab, and pertuzumab (THP) improved pathologic complete response rates compared to the standard neoadjuvant regimen of…
🚨 DESTINY-Breast11: T-DXd followed by THP significantly 🔼pCR vs ddAC-THP in high-risk HER2+ EBC & better safety profile. Neoadjuvant landscape shifting? Excited to see full efficacy + safety data in the paper. @PTarantinoMD @todrashish @OncoAlert @oncodaily @medoncodoc #bcsm
United States Trends
- 1. Cowboys 69.7K posts
- 2. Fred Warner 9,019 posts
- 3. Panthers 70.5K posts
- 4. Zac Taylor 2,591 posts
- 5. Packers 23.3K posts
- 6. Ravens 60.3K posts
- 7. Browns 62K posts
- 8. Dolphins 45.6K posts
- 9. #FTTB 3,490 posts
- 10. #KeepPounding 7,793 posts
- 11. Eberflus 9,610 posts
- 12. Penn State 62K posts
- 13. Colts 55.1K posts
- 14. Cam Ward 1,845 posts
- 15. Steelers 64.6K posts
- 16. #49ers 5,374 posts
- 17. Rico Dowdle 10.6K posts
- 18. Drake Maye 21.8K posts
- 19. Franklin 70.8K posts
- 20. #Bengals 2,239 posts
Something went wrong.
Something went wrong.